Activity 4K. Management of Treatment Interruption with less than 7 Missed Days PDF Share Learning Objective Performance Indicators Provide a rationale for treating all people with HCV except persons with less than a 12-month life expectancy Adhere to inclusion and exclusion criteria for who is eligible to receive simplified HCV treatment Choose an appropriate recommended regimen for simplified HCV treatment Conduct laboratory monitoring for persons receiving simplified HCV treatment, including assessment for sustained virologic response Manage incomplete treatment adherence based on time into treatment and number of days of missed doses Activity QuestionYou should answer this question after completing the activity. You must answer all of the questions before checking your work. This activity has a Check on Learning question. - Show Question A 43-year-old woman with chronic HCV infection met the criteria for the simplified treatment approach and was started on an 8-week treatment course of glecaprevir-pibrentasvir, and she started taking this regimen 3 weeks ago. Now, she is calling the clinic and reporting that she had some recent major stress in her life and missed the past 4 days of her glecaprevir-pibrentasvir medication. Up to that point, she had not missed any doses.What should you advise her regarding her glecaprevir-pibrentasvir dosing? Restart (resume) treatment and complete the scheduled 8-week course Restart (resume) treatment but the treatment course will need to be extended for a total duration of 12 weeks Restart day 1 of treatment and complete an 8-week treatment course Restart (resume) treatment and check a quantitative HCV RNA level and base management on the HCV RNA result Share by e-mail From:Enter your e-mail address To: Enter the e-mail address of the recipient Your Message: Check-On-LearningQuestionsThe Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.You must be signed in to customize your interaction with these questions.
